Characteristics | Median (range) or patient numbers |
---|---|
Age (years) | 66 (32–88) |
Gender (M/F) | 49/6 |
ECOG performance status (0/1) | 50/5 |
Etiology (HBV/HCV/others) | 14/24/17 |
Platelet count (/mm3) | 15.6 (6.4–41.4) |
Total bilirubin (mg/dL) | 0.9 (0.3–1.8) |
Albumin (g/dL) | 3.7 (2.7–5.0) |
Prothrombin consumption test (%) | 78 (57.4–118) |
Child-Pugh score (5/6/7) | 22/23/10 |
Number of liver tumors | 5 (1–40) |
Size of liver tumors (mm) | 85 (18–170) |
Macroscopic vascular invasion (without/with) | 17/38 |
Vp (0–2/3–4)a | 26/29 |
Vv (0–1/2–3) | 46/9 |
Relative tumor size in the liver (<  50%/≥ 50%) | 47/8 |
TACE refractory (without/with) | 42/13 |
Extrahepatic spread (without/with) | 49/6 |
HCC stage (III/IVa/IVb)b | 30/22/3 |
BCLC stage (B/C)c | 18/37 |
AFP (ng/mL) | 1895.2 (2.6–529,500) |
DCP (mAU/mL) | 3854 (24–226,990) |